Breaking News Instant updates and real-time market news.

GMAB

Genmab

$35.37 /

-0.455 (-1.27%)

, JNJ

Johnson & Johnson

$143.94 /

-0.58 (-0.40%)

16:50
10/21/20
10/21
16:50
10/21/20
16:50

Genmab reports 'positive' topline results from Phase 3 CASSIOPEIA study

Genmab (GMAB) announced positive topline results from the second part of the Phase 3 CASSIOPEIA study of daratumumab monotherapy as maintenance treatment versus observation for patients with newly diagnosed multiple myeloma eligible for autologous stem cell transplant. The second part of the study, which is being conducted by the French Intergroupe Francophone du Myelome in collaboration with the Dutch-Belgian Cooperative Trial Group for Hematology Oncology and Janssen Research & Development, LLC (JNJ), met the primary endpoint of improving progression free survival at a pre-planned interim analysis resulting in a 47% reduction in the risk of progression or death in patients treated with daratumumab. The safety profile observed in this study was consistent with the known safety profile of daratumumab and no new safety signals were observed. Based on the results at the pre-planned interim analysis conducted by an Independent Data Monitoring Committee, it was recommended to unblind the study results. Janssen Biotech, Inc., which licensed daratumumab from Genmab in 2012, plans to discuss the potential for a regulatory submission for this indication with health authorities, and plans to submit the data to an upcoming medical conference and for publication in a peer-reviewed journal. "Following the positive data from the first part of the CASSIOPEIA study, we are very pleased to see this benefit. We are appreciative of the efforts of the IFM, of HOVON and of Janssen for their work on this study," said Jan van de Winkel, Ph.D., Chief Executive Officer of Genmab.

GMAB

Genmab

$35.37 /

-0.455 (-1.27%)

JNJ

Johnson & Johnson

$143.94 /

-0.58 (-0.40%)

GMAB Genmab
$35.37 /

-0.455 (-1.27%)

09/23/20 H.C. Wainwright
Genmab price target raised to $42 from $41 at H.C. Wainwright
09/23/20 Bryan Garnier
Genmab downgraded to Sell from Neutral at Bryan Garnier
09/09/20 Jefferies
ASH data could prompt 40% rise, or 70% drop, for IGM Biosciences, says Jefferies
09/08/20 SVB Leerink
Genmab initiated with a Market Perform at SVB Leerink
JNJ Johnson & Johnson
$143.94 /

-0.58 (-0.40%)

10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
10/14/20 Cantor Fitzgerald
Johnson & Johnson price target raised to $180 from $168 at Cantor Fitzgerald
10/13/20 Wells Fargo
Emergent selloff on J&J study pause an overreaction, says Wells Fargo
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.

TODAY'S FREE FLY STORIES

Initiation
Curaleaf initiated with a Buy at Craig-Hallum » 08:30
12/03/20
12/03
08:30
12/03/20
08:30
CURLF

Curaleaf

$0.00 /

+ (+0.00%)

Craig-Hallum analyst Eric…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CURLF Curaleaf
$0.00 /

+ (+0.00%)

CURLF Curaleaf
$0.00 /

+ (+0.00%)

11/18/20 Canaccord
Curaleaf price target raised to C$18.50 from C$16 at Canaccord
11/18/20 Alliance Global Partners
Curaleaf price target raised to C$22 from C$16 at Alliance Global Partners
10/29/20 MKM Partners
Curaleaf upgraded to Buy from Neutral at MKM Partners
08/18/20 Canaccord
Curaleaf price target raised to C$16 from C$15 at Canaccord
CURLF Curaleaf
$0.00 /

+ (+0.00%)

CURLF Curaleaf
$0.00 /

+ (+0.00%)

CURLF Curaleaf
$0.00 /

+ (+0.00%)

Options
Seven new option listings and two option delistings on December 3rd » 08:30
12/03/20
12/03
08:30
12/03/20
08:30
ATRO

Astronics

$12.46 /

+0.43 (+3.57%)

, DPW

DPW Holdings

$4.50 /

-0.04 (-0.88%)

, LAZR

Luminar

$0.00 /

+ (+0.00%)

, PTPI

Petros Pharmaceuticals

$3.86 /

-0.88 (-18.57%)

, SUNW

Sunworks

$4.09 /

-0.16 (-3.76%)

, GMHI

Gores Metropoulos

$18.10 /

+1.1 (+6.47%)

, NTRP

Neurotrope

$0.94 /

-0.01 (-1.05%)

New option listings for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRO Astronics
$12.46 /

+0.43 (+3.57%)

DPW DPW Holdings
$4.50 /

-0.04 (-0.88%)

LAZR Luminar
$0.00 /

+ (+0.00%)

SUNW Sunworks
$4.09 /

-0.16 (-3.76%)

GMHI Gores Metropoulos
$18.10 /

+1.1 (+6.47%)

NTRP Neurotrope
$0.94 /

-0.01 (-1.05%)

ATRO Astronics
$12.46 /

+0.43 (+3.57%)

12/01/20 Truist
Astronics upgraded to Hold from Sell at Truist
12/01/20 Truist
Astronics upgraded to Hold from Sell at Truist
11/20/20 CJS Securities
Astronics upgraded to Outperform from Market Perform at CJS Securities
11/20/20 Canaccord
Canaccord upgrades Astronics, more than doubles target to $15
DPW DPW Holdings
$4.50 /

-0.04 (-0.88%)

LAZR Luminar
$0.00 /

+ (+0.00%)

PTPI Petros Pharmaceuticals
$3.86 /

-0.88 (-18.57%)

SUNW Sunworks
$4.09 /

-0.16 (-3.76%)

04/02/20 Roth Capital
Sunworks downgraded to Neutral from Buy at Roth Capital
GMHI Gores Metropoulos
$18.10 /

+1.1 (+6.47%)

10/14/20 Northland
Gores Metropoulos initiated with an Outperform at Northland
NTRP Neurotrope
$0.94 /

-0.01 (-1.05%)

ATRO Astronics
$12.46 /

+0.43 (+3.57%)

DPW DPW Holdings
$4.50 /

-0.04 (-0.88%)

GMHI Gores Metropoulos
$18.10 /

+1.1 (+6.47%)

GMHI Gores Metropoulos
$18.10 /

+1.1 (+6.47%)

General news
U.S. equity futures are marginally firmer » 08:30
12/03/20
12/03
08:30
12/03/20
08:30

U.S. equity futures are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Standard Lithium completes proof-of-concept of modern lithium processing tech » 08:29
12/03/20
12/03
08:29
12/03/20
08:29
STLHF

Standard Lithium

$0.00 /

+ (+0.00%)

Standard Lithium…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STLHF Standard Lithium
$0.00 /

+ (+0.00%)

STLHF Standard Lithium
$0.00 /

+ (+0.00%)

05/20/20 H.C. Wainwright
Standard Lithium price target raised to C$1.80 from C$1.70 at H.C. Wainwright
Hot Stocks
Talend expands partnership with Snowflake platform » 08:27
12/03/20
12/03
08:27
12/03/20
08:27
TLND

Talend

$37.43 /

-0.275 (-0.73%)

, SNOW

Snowflake

$292.70 /

-13.585 (-4.44%)

Talend (TLND) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLND Talend
$37.43 /

-0.275 (-0.73%)

SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

TLND Talend
$37.43 /

-0.275 (-0.73%)

11/10/20 Citi
Talend price target raised to $60 from $57 at Citi
11/03/20 Citi
Citi opens 'Positive Catalyst Watch' on Talend ahead of earnings
06/29/20 Goldman Sachs
Talend price target raised to $30 from $25 at Goldman Sachs
04/27/20 Needham
Talend price target lowered to $44 from $51 at Needham
SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

08:02 Today Oppenheimer
Snowflake price target raised to $320 from $300 at Oppenheimer
07:41 Today Goldman Sachs
Snowflake price target raised to $308 from $268 at Goldman Sachs
07:28 Today Stifel
Snowflake price target raised to $275 from $250 at Stifel
06:59 Today Deutsche Bank
Snowflake price target raised to $335 from $305 at Deutsche Bank
TLND Talend
$37.43 /

-0.275 (-0.73%)

SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

  • 16
    Sep
SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

TLND Talend
$37.43 /

-0.275 (-0.73%)

SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

SNOW Snowflake
$292.70 /

-13.585 (-4.44%)

Recommendations
XPO Logistics price target raised to $158 from $111 at Wells Fargo » 08:27
12/03/20
12/03
08:27
12/03/20
08:27
XPO

XPO Logistics

$110.00 /

-0.45 (-0.41%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

07:46 Today Oppenheimer
XPO Logistics price target raised to $123 from $108 at Oppenheimer
07:35 Today Raymond James
XPO Logistics price target raised to $135 from $105 at Raymond James
07:22 Today Susquehanna
XPO Logistics spinoff will unlock valuation scenarios, says Susquehanna
07:21 Today KeyBanc
XPO Logistics price target raised to $140 from $125 at KeyBanc
XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

XPO XPO Logistics
$110.00 /

-0.45 (-0.41%)

Hot Stocks
Leaf Group's Society6 announces $21.3M in GTV in November » 08:27
12/03/20
12/03
08:27
12/03/20
08:27
LEAF

Leaf Group

$5.22 /

-0.11 (-2.06%)

Society6 announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEAF Leaf Group
$5.22 /

-0.11 (-2.06%)

LEAF Leaf Group
$5.22 /

-0.11 (-2.06%)

10/16/20 Canaccord
Leaf Group price target raised to $9 from $7 at Canaccord
LEAF Leaf Group
$5.22 /

-0.11 (-2.06%)

LEAF Leaf Group
$5.22 /

-0.11 (-2.06%)

Conference/Events
FDA PDUFA Date for BioCryst Berotralstat (BCX7353) is December 3, 2020  08:26
12/03/20
12/03
08:26
12/03/20
08:26
BCRX

BioCryst

$5.04 /

+0.17 (+3.49%)

 
ShowHide Related Items >><<
BCRX BioCryst
$5.04 /

+0.17 (+3.49%)

BCRX BioCryst
$5.04 /

+0.17 (+3.49%)

11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
11/23/20 Evercore ISI
BioCryst initiated with an Outperform at Evercore ISI
11/05/20 Piper Sandler
Piper Sandler reiterates Overweight rating on BioCryst ahead of 'busy year-end'
09/30/20 Piper Sandler
Piper says BioCryst's early high dose 9930 data 'impressive'
BCRX BioCryst
$5.04 /

+0.17 (+3.49%)

  • 28
    May
BCRX BioCryst
$5.04 /

+0.17 (+3.49%)

BCRX BioCryst
$5.04 /

+0.17 (+3.49%)

Hot Stocks
PolyPid to host KOL call discussing D-PLEX » 08:26
12/03/20
12/03
08:26
12/03/20
08:26
PYPD

PolyPid

$11.28 /

-0.47 (-4.00%)

PolyPid announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PYPD PolyPid
$11.28 /

-0.47 (-4.00%)

PYPD PolyPid
$11.28 /

-0.47 (-4.00%)

11/24/20 Raymond James
Raymond James upgrades PolyPid to Strong Buy after BTD for D-PLEX
11/24/20 Raymond James
PolyPid upgraded to Strong Buy from Outperform at Raymond James
08/10/20 Alliance Global Partners
PolyPid initiated with a Buy at Alliance Global Partners
07/21/20 Raymond James
PolyPid initiated with an Outperform at Raymond James
PYPD PolyPid
$11.28 /

-0.47 (-4.00%)

  • 26
    Jun
PYPD PolyPid
$11.28 /

-0.47 (-4.00%)

Recommendations
PVH Corp. price target raised to $75 from $58 at Wells Fargo » 08:26
12/03/20
12/03
08:26
12/03/20
08:26
PVH

PVH Corp.

$83.54 /

+1.64 (+2.00%)

Wells Fargo analyst Ike…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$83.54 /

+1.64 (+2.00%)

PVH PVH Corp.
$83.54 /

+1.64 (+2.00%)

06:12 Today Piper Sandler
PVH Corp. price target raised to $93 from $69 at Piper Sandler
12/01/20 Morgan Stanley
PVH Corp. price target raised to $90 from $87 at Morgan Stanley
12/01/20 Barclays
PVH Corp. price target raised to $75 from $58 at Barclays
10/26/20 JPMorgan
PVH Corp. price target raised to $66 from $52 at JPMorgan
PVH PVH Corp.
$83.54 /

+1.64 (+2.00%)

PVH PVH Corp.
$83.54 /

+1.64 (+2.00%)

PVH PVH Corp.
$83.54 /

+1.64 (+2.00%)

Technical Analysis
DJ Transportation Average: Pivot points » 08:25
12/03/20
12/03
08:25
12/03/20
08:25
$DJT

DJ Transportation Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$DJT DJ Transportation Average
$0.00 /

+ (+0.00%)

Downgrade
Nutrien downgraded to Neutral from Positive at Susquehanna » 08:25
12/03/20
12/03
08:25
12/03/20
08:25
NTR

Nutrien

/

+

Susquehanna analyst Sandy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTR Nutrien
/

+

NTR Nutrien
/

+

12/01/20 BMO Capital
Nutrien price target raised to $55 from $50 at BMO Capital
09/15/20 Susquehanna
Deteriorating crop conditions positive for fertilizers, says Susquehanna
08/25/20 Atlantic Equities
Nutrien downgraded to Neutral from Overweight at Atlantic Equities
08/12/20 RBC Capital
Nutrien price target raised to $48 from $45 at RBC Capital
NTR Nutrien
/

+

NTR Nutrien
/

+

NTR Nutrien
/

+

Technical Analysis
DJ Utility Average: Pivot points » 08:25
12/03/20
12/03
08:25
12/03/20
08:25
$DJU

DJ Utility Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$DJU DJ Utility Average
$0.00 /

+ (+0.00%)

Conference/Events
Morgan Stanley large cap banks analyst to hold analyst/industry conference call » 08:25
12/03/20
12/03
08:25
12/03/20
08:25

US Large Cap Banks &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
UBS healthcare analysts hold analyst/industry conference call » 08:25
12/03/20
12/03
08:25
12/03/20
08:25

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
LPL Financial price target raised to $110 from $92 at Wells Fargo » 08:24
12/03/20
12/03
08:24
12/03/20
08:24
LPLA

LPL Financial

$95.13 /

+1.755 (+1.88%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LPLA LPL Financial
$95.13 /

+1.755 (+1.88%)

LPLA LPL Financial
$95.13 /

+1.755 (+1.88%)

11/17/20 Citi
LPL Financial price target raised to $145 from $132.50 at Citi
11/11/20 Citi
LPL Financial price target raised to $132.50 from $113.50 at Citi
09/08/20 Citi
LPL Financial price target raised to $118.50 from $111 at Citi
08/13/20 Barclays
LPL Financial initiated with an Overweight at Barclays
LPLA LPL Financial
$95.13 /

+1.755 (+1.88%)

Technical Analysis
Dow Jones Industrial Average: Pivot points » 08:24
12/03/20
12/03
08:24
12/03/20
08:24
DJX

Dow Jones Industrial Average

$0.00 /

+ (+0.00%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

DJX Dow Jones Industrial Average
$0.00 /

+ (+0.00%)

Technical Analysis
iShares Transportation Average: Pivot points » 08:24
12/03/20
12/03
08:24
12/03/20
08:24
IYT

iShares Transportation Average

$221.64 /

+0.99 (+0.45%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IYT iShares Transportation Average
$221.64 /

+0.99 (+0.45%)

Hot Stocks
Enlivex Therapeutics reports results from Phase II trial of Allocetra » 08:24
12/03/20
12/03
08:24
12/03/20
08:24
ENLV

Enlivex Therapeutics

$8.23 /

+0.03 (+0.37%)

Enlivex Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENLV Enlivex Therapeutics
$8.23 /

+0.03 (+0.37%)

ENLV Enlivex Therapeutics
$8.23 /

+0.03 (+0.37%)

03/10/20 H.C. Wainwright
Enlivex Therapeutics price target raised to $22 from $20 at H.C. Wainwright
01/09/20 H.C. Wainwright
Enlivex Therapeutics initiated with a Buy at H.C. Wainwright
ENLV Enlivex Therapeutics
$8.23 /

+0.03 (+0.37%)

Technical Analysis
Technology Select Sector SPDR: Pivot points » 08:24
12/03/20
12/03
08:24
12/03/20
08:24
XLK

Technology Select Sector SPDR

$124.93 /

-0.21 (-0.17%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLK Technology Select Sector SPDR
$124.93 /

-0.21 (-0.17%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLK Technology Select Sector SPDR
$124.93 /

-0.21 (-0.17%)

XLK Technology Select Sector SPDR
$124.93 /

-0.21 (-0.17%)

Technical Analysis
Energy Select Sector SPDR: Pivot points » 08:23
12/03/20
12/03
08:23
12/03/20
08:23
XLE

Energy Select Sector SPDR

$38.12 /

+1.18 (+3.19%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLE Energy Select Sector SPDR
$38.12 /

+1.18 (+3.19%)

XLE Energy Select Sector SPDR
$38.12 /

+1.18 (+3.19%)

07/06/20 Goldman Sachs
Rattler Midstream downgraded to Neutral from Buy at Goldman Sachs
XLE Energy Select Sector SPDR
$38.12 /

+1.18 (+3.19%)

Hot Stocks
Luokung Technology, Hainan Broadcasting enter cooperation agreement » 08:23
12/03/20
12/03
08:23
12/03/20
08:23
LKCO

Luokung Technology

$0.56 /

-0.0298 (-5.05%)

Luokung Technology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LKCO Luokung Technology
$0.56 /

-0.0298 (-5.05%)

Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points » 08:23
12/03/20
12/03
08:23
12/03/20
08:23
XLY

Consumer Discretionary Sector SPDR

$157.45 /

-1.02 (-0.64%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLY Consumer Discretionary Sector SPDR
$157.45 /

-1.02 (-0.64%)

03/18/20
Jefferies ups Health Care to Overweight, cuts Discretionary to Underweight
XLY Consumer Discretionary Sector SPDR
$157.45 /

-1.02 (-0.64%)

XLY Consumer Discretionary Sector SPDR
$157.45 /

-1.02 (-0.64%)

Technical Analysis
S&P Select Materials SPDR: Pivot points » 08:23
12/03/20
12/03
08:23
12/03/20
08:23
XLB

S&P Select Materials SPDR

$70.85 /

-0.93 (-1.30%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLB S&P Select Materials SPDR
$70.85 /

-0.93 (-1.30%)

06/10/20 Jefferies
Jefferies downgrades Tech sector to Market Weight from Overweight
XLB S&P Select Materials SPDR
$70.85 /

-0.93 (-1.30%)

XLB S&P Select Materials SPDR
$70.85 /

-0.93 (-1.30%)

Technical Analysis
Utilities SPDR: Pivot points » 08:23
12/03/20
12/03
08:23
12/03/20
08:23
XLU

Utilities SPDR

$63.72 /

+0.43 (+0.68%)

The following are the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLU Utilities SPDR
$63.72 /

+0.43 (+0.68%)

10/21/20 Jefferies
Jefferies upgrades Utilities sector to Market Weight from Underweight
10/19/20 Goldman Sachs
Essential Utilities upgraded to Conviction Buy from Neutral at Goldman Sachs
01/15/20 Goldman Sachs
Avangrid downgraded to Sell from Neutral at Goldman Sachs
XLU Utilities SPDR
$63.72 /

+0.43 (+0.68%)

XLU Utilities SPDR
$63.72 /

+0.43 (+0.68%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.